116 related articles for article (PubMed ID: 21091879)
1. Circulating sex hormones play no role in the association between sexual activity and the risk of prostate cancer.
Ahmadi H; Allameh F; Baradaran N; Montaser-Kouhsari L; Bazargan-Hejazi S; Salem S; Mehrsai A; Pourmand G
J Sex Med; 2011 Mar; 8(3):905-13. PubMed ID: 21091879
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones.
Baradaran N; Ahmadi H; Salem S; Lotfi M; Jahani Y; Baradaran N; Mehrsai AR; Pourmand G
Prostate; 2009 Dec; 69(16):1744-50. PubMed ID: 19676082
[TBL] [Abstract][Full Text] [Related]
3. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
4. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men.
Honda GD; Bernstein L; Ross RK; Greenland S; Gerkins V; Henderson BE
Br J Cancer; 1988 Mar; 57(3):326-31. PubMed ID: 3355774
[TBL] [Abstract][Full Text] [Related]
5. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
6. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
7. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
8. Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy.
Salonia A; Abdollah F; Capitanio U; Suardi N; Briganti A; Gallina A; Colombo R; Ferrari M; Castagna G; Rigatti P; Montorsi F
Clin Cancer Res; 2012 Jul; 18(13):3648-57. PubMed ID: 22589393
[TBL] [Abstract][Full Text] [Related]
9. Physical characteristics and factors related to sexual development and behaviour and the risk for prostatic cancer.
Hayes RB; de Jong FH; Raatgever J; Bogdanovicz J; Schroeder FH; van der Maas P; Oishi K; Yoshida O
Eur J Cancer Prev; 1992 Apr; 1(3):239-45. PubMed ID: 1467769
[TBL] [Abstract][Full Text] [Related]
10. Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials.
Cunningham GR; Stephens-Shields AJ; Rosen RC; Wang C; Ellenberg SS; Matsumoto AM; Bhasin S; Molitch ME; Farrar JT; Cella D; Barrett-Connor E; Cauley JA; Cifelli D; Crandall JP; Ensrud KE; Fluharty L; Gill TM; Lewis CE; Pahor M; Resnick SM; Storer TW; Swerdloff RS; Anton S; Basaria S; Diem S; Tabatabaie V; Hou X; Snyder PJ
J Clin Endocrinol Metab; 2015 Mar; 100(3):1146-55. PubMed ID: 25548978
[TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
12. Hypogonadism in male patients with cancer.
Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
[TBL] [Abstract][Full Text] [Related]
13. Hormonal predictors of prostate cancer: a meta-analysis.
Shaneyfelt T; Husein R; Bubley G; Mantzoros CS
J Clin Oncol; 2000 Feb; 18(4):847-53. PubMed ID: 10673527
[TBL] [Abstract][Full Text] [Related]
14. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
[TBL] [Abstract][Full Text] [Related]
15. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
[TBL] [Abstract][Full Text] [Related]
16. The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males.
Moreno-Pérez O; Escoín C; Serna-Candel C; Portilla J; Boix V; Alfayate R; González-Sánchez V; Mauri M; Sánchez-Payá J; Picó A
J Sex Med; 2010 Aug; 7(8):2873-83. PubMed ID: 20626606
[TBL] [Abstract][Full Text] [Related]
17. Absence of relationship between steroid hormone levels and prostate cancer tumor grade.
Sher DJ; Mantzoros C; Jacobus S; Regan MM; Lee GS; Oh WK
Urology; 2009 Feb; 73(2):356-61; discussion 361-2. PubMed ID: 19036418
[TBL] [Abstract][Full Text] [Related]
18. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
Rannikko S; Adlercreutz H
Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
[TBL] [Abstract][Full Text] [Related]
19. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
20. Plasma sex steroid hormones and breast cancer risk in Chinese women.
Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
